Antibodies are central to immunology and therapeutics, and understanding how they recognize antigens is essential to rational drug design. This recognition depends on the interplay of interface geometry, physicochemical interactions, sequence context, and complementarity-determining region (CDR) conformation. However,...
Ting-Wei Miao, Ruo-Han Zhu, Rui-Qi Lin et al.· bioRxiv· 0 citations
Metabolic reprogramming is a fundamental regulator of immune cell fate and function in the tumor microenvironment (TME), though the relative contributions of individual metabolic pathways vary across immune cell subsets, tumor types, and disease stages. Competition for nutrients, hypoxia, and the accumulation of immuno...
Yi-Qing Jiang, Yan-Ling Wu, Tian-Lei Ying· Cancer Biome and Targeted Th...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.